Satellite Symposium at the Congress of the International Academy of Pathology
CD30 detection in haematological malignancies: diagnosis and therapeutics
7 October 2014 12:00-13:30
Bangkok Convention Centre at CentralWorld, Bangkok, Thailand
Lotus 1-4

Yok Lam Kwong, MD, FRCP, FRCPath, FHKCP, FHKCPath, FHKAM (Medicine), FHKAM (Pathology)

Yok Lam Kwong is chief of the Division of Haematology, Oncology, and Bone Marrow Transplantation in the Department of Medicine, University of Hong Kong, Hong Kong. He is specialized in haematology and haematopathology.

Professor Kwong’s clinical work focuses on the management of haematological malignancies. His team has especial interests in the treatment of leukaemias and T-cell and natural killer cell malignancies. His research centres on the molecular pathogenetic pathways and novel treatment modalities in haematological neoplasms. Together with the clinical pharmacology team in his department, Professor Kwong has pioneered the development and use of oral arsenic trioxide in the treatment of acute promyelocytic leukaemia and other blood cancers. His research team is also actively involved in defining the molecular defects and optimal treatment protocols for T-cell and natural killer cell lymphomas, which are neoplasms prevalent in Asian populations.

 

 

 

 

 

 

 

 

 

Chair:

Stefano Pileri
Italy
Faculty:

Koichi Ohshima
Japan

Leonard Hwan Cheong Tan
Singapore

Yok Lam Kwong
This meeting is an
Excerpta Medica activity.
logos
Support for this educational activity is provided by
Takeda Oncology.
logos